Dhipatimendi rePasi Pose

Musi wa11 Chikumi, Kelun-Biotech yakazivisa kuti yakagadzira yega mushonga weTROP2 ADC sac-TMT (佳泰莱), pamwe chete nePD-L1 monoclonal antibody tagitanlimab (科泰莱), yakapihwa Breakthrough Therapy Designation (BTD) neCenter for Drug Evaluation (CDE) yeNational Med...Verenga zvakawanda»

Musi wa29 Chivabvu, National Medical Products Administration (NMPA) yakabvumidza kutengeswa kweZanidatamab, yakatumirwa neBeiGene, yekurapa varwere vane kenza yemudumbu isingarapike kana kuti ine metastatic biliary tract cancer (BTC) avo vakamborapwa nesystemic therapy uye vakaratidza HER2 yakakwira...Verenga zvakawanda»

Musi wa4 Chikumi, 2025, Akeso akazivisa kuti National Medical Products Administration (NMPA) yabvumidza mushonga wekutanga wePD-1/CTLA-4 bispecific antibody wekambani, cadonilimab, wekurapa kenza yemuchibereko inoramba iripo, inodzokororwa, kana kuti yakapararira, pamwe chete neplatinu...Verenga zvakawanda»

Musi wa29 Chivabvu, National Medical Products Administration (NMPA) yakabvumidza mushonga weHER2-targeted antibody-drug conjugate (ADC) trastuzumab rezetecan (SHR-A1811) wekutengesa. Unoratidzwa semushonga mumwe chete wekurapa varwere vakuru vane chirwere chisina kubviswa chepamberi kana kuti chisingaperi ...Verenga zvakawanda»

Musi wa21 Chivabvu, 2025, InnoCare Pharma yakazivisa kuti China National Medical Products Administration (NMPA) yabvumidza Minjuvi® (tafasitamab), mushonga weFc-modified cytolytic CD19 unorwisa monoclonal antibody, pamwe chete nelenalidomide, uchiteverwa neMinjuvi monotherapy, yekurapa...Verenga zvakawanda»

Musi wa22 Chivabvu, 2025, Allist Pharmaceuticals yakazivisa kuti mushonga wayo mutsva weAirukai (Glecirasib Citrate Tablets), mushonga unodzivirira KRAS-G12C, wabvumidzwa zviri pamutemo kuti utange kushandiswa pamusika neNational Medical Products Administration (NMPA). Kubvumidzwa uku kunobvumira Airuikai kushandiswa pakurapa...Verenga zvakawanda»

Musi wa22 Chivabvu, 2025, Kelun Bio yakazivisa kuti chikumbiro chechiratidzo chitsva che trophoblast cell surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, inozivikanwawo seSKB264/MK – 2870) (®) chakagamuchirwa neCenter for Drug Evaluation (...Verenga zvakawanda»

Muhondo Yenguva Refu Yekurwisa Gomarara, Zvombo Zvitsva Zvinorwisa Gomarara Zvinoramba Zvichibuda, Zvichiunza Tariro Itsva Kuvarwere Muhondo yakareba pakati pevanhu negomarara, zvombo zvitsva zvinorwisa gomarara zviri kubuda chimwe mushure mechimwe, zvichiunza tariro itsva kuvarwere. Sechinhu chitsva chinopenya...Verenga zvakawanda»

Muna 2021, murwere ane makore 67 ekuberekwa ane kenza yepancreas akaita chishamiso chekurapa. Mushure mekuvhiyiwa, kurapwa kakawanda nechemotherapy, uye kukundikana kweTIL therapy, kuyedzwa kwekiriniki kweTCR-T cell therapy yaakapinda mairi kwakaita kuti metastases yemapapu iderere ne72% mukati memwedzi mitanhatu...Verenga zvakawanda»

Musi wa12 Chivabvu, 2025, CARsgen yakazivisa ruzivo rwekutanga rwekiriniki yeCT0596, iyo CAR-T inotarirwa neBCMA yakagadzirwa ichishandisa puratifomu yeTHANK-u Plus™. CT0596 parizvino iri kuongororwa muchidzidzo chekutanga chekiriniki chekuongorora myeloma yakadzoka/yakasaririra (R/R MM) kana yakadzoka/yakasaririra...Verenga zvakawanda»

Musi wa9 Chivabvu, 2025, Hansoh Pharmaceutical yakazivisa kuti chiratidzo chitsva cheAmeile (mapiritsi ealmonertinib mesylate) chabvumidzwa kutengeswa. Chiratidzo chitsva ndechekurapa varwere vakuru vane kenza yemapapu isiri diki (NSCLC) vane bundu rine epidermal growth factor re...Verenga zvakawanda»

Musi wa1 Chivabvu 2025, Hansoh Pharmaceutical yakazivisa kuti mushonga weB7-H4-targeted antibody-drug conjugate (ADC) HS-20089 weBoka wakazvigadzira wega wekubaiwa jekiseni wawana mvumo yekuverengerwa semushonga weBreakthrough-Therapy-Designated neNational Medical Products Administration (NMPA) yeChina, une...Verenga zvakawanda»